A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A S (Q44594900)
scientific article published in December 1998
Language:
(P31) (Q13442814)
(P50) (Q63847562)
(P304) 339-349
(P407) (Q1860)
(P433) 4
(P478) 19
(P577) Tuesday, December 1, 1998
(P1433) (Q6294722)
(P1476) "A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A S" (language: en)
(P2093) Henry K
Erice A
Tierney C
Balfour HH Jr
Kmack A
Liou SH
Kenton A
Hirsch MS
Phair J
Martinez A
Kahn JO
other details
description scientific article published in December 1998

External Links